Prazosin Hydrochloride

盐酸哌唑嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePrazosin Hydrochloride
Drug Alias Name盐酸呱唑嗪PrazosinaPrazosine哌唑嗪盐酸盐Prazosinum +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonists
TargetsAdrenergic receptors
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Stress Disorders, Post-TraumaticAnxiety Disorders +[11] 
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1976/06/23
Country/TerritoryBelgiumCanadaUnited States +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesYale UniversityPfizer IncNational Institute On Aging (NIA) +[4] 
Inactive CompaniesAugusta UniversityUniversity Of ManitobaJohns Hopkins University +[5] 
Active IndicationsAlcohol AbstinenceProblem BehaviorHypertension +[5] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Stress Disorders, Post-TraumaticAnxiety Disorders +[6] 

Other Information

ATC CodeC02CA01
Related LinksWikipediaDrugBankKEGG